Research progress on animal models of cardiac hypertrophy and compensation mechanisms
Author:
Affiliation:

1.Beijing Engineering Research Center for Experimental Animal Models of Human Diseases, Institute of Laboratory Animal Science, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China. 2. Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Cardiac hypertrophy is a slow and effective compensatory function that mainly occurs under long-term stress loads. It is an adaptive response to changes in hemodynamics or myocardial injury. Decompensation of myocardial hypertrophy can eventually lead to an increased incidence of heart failure and sudden death, and no effective treatments have been established. In this paper, we summarize and compare the preparation method and characteristics of animal models of cardiac hypertrophy, including mice, rats, and large animals. We also summarize and compare the classical molecular signaling mechanisms of cardiac hypertrophy, including the mitotic protein kinase signaling pathway and the Ca2+ mediated signaling pathway, as well as the molecular mechanisms of decompensation induced by cardiac hypertrophy, including catecholamine and the cardiomyocyte apoptosis signaling pathway.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 01,2020
  • Revised:
  • Adopted:
  • Online: September 02,2020
  • Published: